Immune response to influenza vaccination in a large healthy elderly population

Vaccine

Volumn 17, Issue 1, 1999, Pages 82-94

  Bernstein, E ^a   Kaye, D ^a   Abrutyn, E ^a   Gross, P ^b   Dorfman, M ^a   Murasko, D M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Cell mediated immunity; Elderly; Humoral immunity; Influenza vaccination

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; VIRUS ANTIBODY;

AGED; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RETIREMENT;

AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0032889359     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00117-0     Document Type: Article

References (55)

1. Cate T.R. Clinical manifestations and consequences of influenza. Am. J. Med. 82(Suppl 6A):1987;15-19.
2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1995; 44:1-22.
3. Couch, R.B. Summary of medical literature. Review of effectiveness of inactivated influenza virus vaccine. In: Cost Effectiveness of Influenza Vaccination. Office of Technology Assessment, Washington, DC, 1981, pp. 43-45.
4. Brandiss M.W., Betts R.F., Mathur U., Douglas R.G. Responses of elderly subjects to monovalent A/USSR/77(H1N1) and trivalent A/USSR/77(H1N1) - A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines. Am. Rev. Resp. Dis. 124:1981;681-684.
5. Gravenstein S., Drinka P.J., Duthie E.H.et al. Risks for influenza and respiratory illness in vaccinated elderly. Aging: Immunol. Infect. Dis. 2:1990;185-193.
6. Gross P.A., Hermogenes A.W., Sacks H.S.et al. The efficacy of influenza vaccines in elderly persons: a meta analysis and review of the literature. Ann. Intern. Med. 123:1991;518-527.
7. Govaert T.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 272:1994;1661-1665.
8. Arden NH, Patriarca PA, Kendal AP. In: Options for the Control of Influenza. AR Liss Inc., New York, 1986, pp. 155-168.
9. Pereira M.S., Chakraverty P., Schild G.C., Coleman M.T., Dowdle W.R. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Brit. Med. J. 4:1972;701-703.
10. Goodeve A., Potter C.W., Clark A., Jennings R., Schild G.C., Yetts R. A graded dose study of inactivated surface antigen influenza B vaccine in volunteers. J. Hyg. Camb. 90:1983;107-115.
11. Keren G., Segev S., Morag A., Zakay-Rones Z., Barzilai A., Rubenstein E. Failure of influenza vaccination in the aged. J. Med. Virol. 25:1988;85-89.
12. Gross P.A., Quinnan G.V., Weksler M.E., Gaerlan P.F., Denning C.R. Immunization of elderly people with high doses of influenza vaccine. J. Am. Geriatr. Soc. 36:1988;209-212.
13. Beyer W.E.P., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7:1989;385-394.
14. Gravenstein S., Drinka P.J., Duthie E.H., Miller B.A., Brown C.S., Hensley M., Circo R., Langer E., Ershler W.B. Efficacy of an influenza hemagglutinin-diptheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J. Am. Geriatr. Soc. 42:1994;245-251.
15. Yap K.L., Ada G.L., McKenzie I.F.C. Transfer of specific cytotoxic T-lymphocytes protects mice inoculated with influenza virus. Nature. 273:1978;238-239.
16. McMichael A.J., Gotch F.M., Dongworth D.W., Clark A., Potter C.W. Declining T-cell immunity to influenza, 1977-82. Lancet. 2:1983;762-764.
17. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N. Eng. J. Med. 309:1983;13-17.
18. Taylor P.M., Askonas B.A. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 58:1986;417-420.
19. Jennings R., Fenton R.J., McEntegart M.G., Potter C.W. A contribution of cellular immunity to protection against influenza in man. Med. Microbiol. Immunol. 166:1978;51.
20. Askonas BA, McMichael AJ, Webster, RG. The immune response to influenza viruses and the problem of protection against infection. In: Basic and Applied Influenza Research (Ed. Beare AS). CRC Press, Boca Raton, FL, 1982, pp. 159-187.
21. Bender B.S., Johnson M.P., Small P.A. Influenza in senescent mice: impaired cytotoxic activity T-lymphocyte is correlated with prolonged infection. Immunology. 72:1991;514-519.
22. Bender BS, Johnson MP, Flexner C, et al. Cytotoxic-T-lymphocyte activity induced by influenza vaccination in young and aged mice. In: Modern Approaches to New Vaccines Including Prevention of AIDS (Eds Brown F, Chanock RM, Ginsberg HS, et al). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1990, pp. 69-73.
23. McMichael A. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Micro. Immunol. 189:1994;75-91.
24. Murasko D.M., Goonewardene I.M. T cell function in aging: mechanisms of decline. Ann. Rev. Gerontol. Geriatrics. 10:1990;71-96.
25. Havel E.A., Vilcek J. Production of high-titered IFN in cultures of human diploid cells. Antimicrob. Agent. Chemother. 2:1972;476-482.
26. Harmon MW, Kendal AP. Influenza viruses. In: (Eds Schmidt NJ Emmans RW). Diagnostic Procedures for Viral Rickettsial and Chylamydial Infections, 6th ed. Am. Pub. Health Assoc. Washington, DC, 1989, pp. 631-668.
27. Advanced Laboratory Techniques for Influenza Diagnosis. U.S. Dept. of HEW, Public Health Service, CDC, Atlanta, GA, 1975.
28. Gross P.A., Quinnan G.V., Weksler M.E., Setia U., Douglas R.G. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine. 7:1989;303-308.
29. Gross P.A., Weksler M.E., Quinnan G.V., Douglas R.G., Gaerlan P.F., Denning C.R. Immunization of elderly people with two doses of influenza vaccine. J. Clin. Microbiol. 25:1987;1763-1765.
30. Serie C., Barme M., Hannoun C., Thibon M., Beck H., Aquino J.P. Effects of vaccination on an influenza epidemic in a geriatric hospital. Dev. Biol. Standard. 39:1977;317-321.
31. Gross P.A., Quinnan G.V., Rodstein M., LaMontagne J.R., Kaslow R.A., Saah A.J., Wallenstein S., Neufeld R., Denning C., Gaerlan P. Association of influenza immunization with reduction in mortality in an elderly population. Arch. Int. Med. 148:1988;562-565.
32. Patriarca P.A., Weber J.A., Parker R.A., Hall W.N., Kendal A.P., Bregman D.J., Schonberger L.B. Efficacy of influenza vaccine in nursing homes. JAMA. 253:1985;1136-1139.
33. Betts RF, Dolin R, Treanor JJ, et al. Inactivated influenza vaccine reduces frequency and severity of illness in the elderly, 24th ICAAC Washington, DC. Am. Soc. Micro., 1984, Abstract 289.
34. Saah A.J., Neufeld R., Rodstein M., LaMontagne J.R., Blackwelder W.C., Gross P., Quinnan G., Kaslow R.A. Influenza vaccine and pneumonia mortality in a nursing home population. Arch. Int. Med. 146:1986;2353-2357.
35. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Eng. J. Med. 331:1994;778-784.
36. Powers D.C., Belshe R.B. Effect of age on cytotoxic T-lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 167:1993;584-592.
37. Fagiolo U., Amadori A., Cozzi E., Bendo R., Lama M., Douglas A., Palu G. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging Clin. Exp. Res. 5:1993;451-458.
38. Gorse G.J., Belshe R.B. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J. Clin. Microbiol. 28(11):1990;2539-2550.
39. Powers D.C. Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults. Mech. Aging Dev. 93:1997;179-188.
40. Gorse G.J., Campbell M.J., Otto E.E., Powers D.C., Chambers G.W., Newman F.K. Increased anti-influenza A virus cytotoxic T-cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J. Infect. Dis. 172:1995;1-10.
41. Powers D.C., Manning M.C., Hanscome P.J., Pietrobon P.J. Cytotoxic T-lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. J. Infect. Dis. 172:1995;1103-1107.
42. McElhaney J.E., Pinkoski M.J., Au D., Lechelt K.E., Bleackly R.C., Meneilly G.S. Helper and cytotoxic T-lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine. 14(6):1996;539-544.
43. Degelau J.J., O'Leary J.J., Hallgren H.M. Relationship of memory and naïve T-cell subsets to diminished influenza vaccination response in nursing home elderly. Aging: Immunol. Infect. Dis. 5(1):1994;27-41.
44. Schwab R., Russo R., Weksler M.E. Loss of MHC-restricted T-cell recognition of influenza antigens in aging. Aging: Immunol. Infect. Dis. 2(3):1990;111-116.
45. McElhaney J.E., Beattie B.L., Devine R., Grynoch R., Toth E.L., Bleakley R.C. Age-related decline in interleukin 2 production in response to influenza vaccine. J. Am. Geriatr. Soc. 38:1990;652-658.
46. Saririan K.K., Contini P., Indiveri F. Serum HLA class 1 levels in elderly humans: utilization in following the response to influenza vaccine. Human Immunology. 40:1994;202-209.
47. Murasko D.M., Nelson B.J., Matour D., Goonewardene I.M., Kaye D. Heterogeneity of changes in lymphoproliferative ability with increasing age. Exp. Gerontol. 26:1991;269.
48. Murasko D.M., Nelson B.J., Silver R., Matour D., Kaye D. Immunological response of an elderly population: Mean age 85. Am. J. Med. 81:1986;612-618.
49. Murasko D.M., Weiner P., Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp. Immunol. 70:1987;440-448.
50. Barcellini W., Borghi M.O., Sguotti C., Palmieri R., Frasca D., Meroni P.L., Doria G., Zanussi C. Heterogeneity of immune responsiveness in healthy elderly subjects. Clin. Immun. Immunopath. 47:1988;142-151.
51. McElhaney J.E., Meneilly G.S., Beattie B.L., Helgason C.D., Lee S.F., Devine R.D., Bleackley R.C. The effect of influenza vaccination on IL-2 production in healthy elderly: implications for current practices. J. Geront. 47(1):1992;M3-8.
52. McElhaney J.E., Pinkoski M.J., Meneilly G.S. Changes in CD45 isoform expression after influenza vaccination. Mech. Aging Dev. 69:1993;79-91.
53. Powers D.C., McElhaney J.E., Florendo O.A., Manning M.C., Upshaw C.M.et al. Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus. J. Infect. Dis. 175:1997;342-351.
54. Tomoda Y., Morita H., Kurashige T., Maasab H.F. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-g production and local IgA response. Vaccine. 13(2):1995;185-190.
55. Gluck R., Mischler R., Finkel B., Que J.U., Scarpa B., Cryz S.J. Jr. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet. 344:1994;160-163.